173 related articles for article (PubMed ID: 24481662)
21. Increased expression of extracellular matrix metalloproteinase inducer is associated with matrix metalloproteinase-1 and -2 in gingival tissues from patients with periodontitis.
Dong W; Xiang J; Li C; Cao Z; Huang Z
J Periodontal Res; 2009 Feb; 44(1):125-32. PubMed ID: 19515022
[TBL] [Abstract][Full Text] [Related]
22. EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma.
Davidson B; Goldberg I; Berner A; Kristensen GB; Reich R
Clin Exp Metastasis; 2003; 20(2):161-9. PubMed ID: 12705637
[TBL] [Abstract][Full Text] [Related]
23. High serum alkaline phosphatase cooperating with MMP-9 predicts metastasis and poor prognosis in patients with primary osteosarcoma in Southern China.
Han J; Yong B; Luo C; Tan P; Peng T; Shen J
World J Surg Oncol; 2012 Feb; 10():37. PubMed ID: 22333159
[TBL] [Abstract][Full Text] [Related]
24. Extracellular matrix metalloproteinase inducer (EMMPRIN) and matrix metalloproteinases (MMPs) as regulators of tumor-host interaction in a spontaneous metastasis model in rats.
Donadio AC; Remedi MM; Susperreguy S; Frede S; Gilardoni MB; Tang Y; Pellizas CG; Yan L
Histochem Cell Biol; 2008 Dec; 130(6):1155-64. PubMed ID: 18769934
[TBL] [Abstract][Full Text] [Related]
25. EMMPRIN-mediated induction of uterine and vascular matrix metalloproteinases during pregnancy and in response to estrogen and progesterone.
Dang Y; Li W; Tran V; Khalil RA
Biochem Pharmacol; 2013 Sep; 86(6):734-47. PubMed ID: 23856290
[TBL] [Abstract][Full Text] [Related]
26. Glioma cell extracellular matrix metalloproteinase inducer (EMMPRIN) (CD147) stimulates production of membrane-type matrix metalloproteinases and activated gelatinase A in co-cultures with brain-derived fibroblasts.
Sameshima T; Nabeshima K; Toole BP; Yokogami K; Okada Y; Goya T; Koono M; Wakisaka S
Cancer Lett; 2000 Sep; 157(2):177-84. PubMed ID: 10936678
[TBL] [Abstract][Full Text] [Related]
27. Expression of EMMPRIN in adenoid cystic carcinoma of salivary glands: correlation with tumor progression and patients' prognosis.
Yang X; Dai J; Li T; Zhang P; Ma Q; Li Y; Zhou J; Lei D
Oral Oncol; 2010 Oct; 46(10):755-60. PubMed ID: 20850374
[TBL] [Abstract][Full Text] [Related]
28. Highly expressed tumoral emmprin and stromal CD73 predict a poor prognosis for external auditory canal carcinoma.
Miyazaki M; Aoki M; Okado Y; Koga K; Hamasaki M; Nakagawa T; Sakata T; Nabeshima K
Cancer Sci; 2020 Aug; 111(8):3045-3056. PubMed ID: 32473077
[TBL] [Abstract][Full Text] [Related]
29. Expression of MMP-2, -7, -9, MT1-MMP and TIMP-1 and -2 has no prognostic relevance in patients with advanced epithelial ovarian cancer.
Brun JL; Cortez A; Lesieur B; Uzan S; Rouzier R; Daraï E
Oncol Rep; 2012 Apr; 27(4):1049-57. PubMed ID: 22200690
[TBL] [Abstract][Full Text] [Related]
30. Upstream regulation of matrix metalloproteinase by EMMPRIN; extracellular matrix metalloproteinase inducer in advanced atherosclerotic plaque.
Yoon YW; Kwon HM; Hwang KC; Choi EY; Hong BK; Kim D; Kim HS; Cho SH; Song KS; Sangiorgi G
Atherosclerosis; 2005 May; 180(1):37-44. PubMed ID: 15823273
[TBL] [Abstract][Full Text] [Related]
31. Extracellular matrix metalloproteinase inducer: a novel poor prognostic marker for human seminomas.
Bi XC; Liu JM; He HC; Ye YK; Han ZD; Dai QS; Liang YX; Cai C; Chen JH; Chen XB; Qin GQ; Zeng GH; Zhong WD
Clin Transl Oncol; 2012 Mar; 14(3):190-6. PubMed ID: 22374422
[TBL] [Abstract][Full Text] [Related]
32. Role of emmprin in endometrial cancer.
Nakamura K; Kodama J; Hongo A; Hiramatsu Y
BMC Cancer; 2012 May; 12():191. PubMed ID: 22640183
[TBL] [Abstract][Full Text] [Related]
33. Malignant Fibrous Histiocytoma, Aggressive Fibromatosis and Benign Fibrous Tumors Express mRNA for the Metalloproteinase Inducer EMMPRIN and the Metalloproteinases MMP-2 and MT1-MMP.
Ahlén J; Enberg U; Larsson C; Larsson O; Frisk T; Brosjö O; Rosen A; Bäckdahl M
Sarcoma; 2001; 5(3):143-9. PubMed ID: 18521441
[TBL] [Abstract][Full Text] [Related]
34. Urine matrix metalloproteinases and their extracellular inducer EMMPRIN in children with chronic kidney disease.
Musiał K; Bargenda A; Zwolińska D
Ren Fail; 2015 Jul; 37(6):980-4. PubMed ID: 25945606
[TBL] [Abstract][Full Text] [Related]
35. EMMPRIN is an independent negative prognostic factor for patients with astrocytic glioma.
Tian L; Zhang Y; Chen Y; Cai M; Dong H; Xiong L
PLoS One; 2013; 8(3):e58069. PubMed ID: 23516431
[TBL] [Abstract][Full Text] [Related]
36. Matrix metalloproteinase (MMP) induction and inhibition at different doses of recombinant tissue plasminogen activator following experimental stroke.
Burggraf D; Martens HK; Dichgans M; Hamann GF
Thromb Haemost; 2007 Nov; 98(5):963-9. PubMed ID: 18000599
[TBL] [Abstract][Full Text] [Related]
37. Matrix metalloproteinase 9 expression and survival of patients with osteosarcoma: a meta-analysis.
Liu Y; Wang Y; Teng Z; Chen J; Li Y; Chen Z; Li Z; Zhang Z
Eur J Cancer Care (Engl); 2017 Jan; 26(1):. PubMed ID: 26239566
[TBL] [Abstract][Full Text] [Related]
38. Extracellular matrix metalloproteinase inducer (EMMPRIN) remodels the extracellular matrix through enhancing matrix metalloproteinases (MMPs) and inhibiting tissue inhibitors of MMPs expression in HPV-positive cervical cancer cells.
Xu Q; Cao X; Pan J; Ye Y; Xie Y; Ohara N; Ji H
Eur J Gynaecol Oncol; 2015; 36(5):539-45. PubMed ID: 26513879
[TBL] [Abstract][Full Text] [Related]
39. Direct cell-cell interaction enhances pro-MMP-2 production and activation in co-culture of laryngeal cancer cells and fibroblasts: involvement of EMMPRIN and MT1-MMP.
Suzuki S; Sato M; Senoo H; Ishikawa K
Exp Cell Res; 2004 Feb; 293(2):259-66. PubMed ID: 14729463
[TBL] [Abstract][Full Text] [Related]
40. p16 expression as a prognostic and predictive marker in high-grade localized osteosarcoma of the extremities: an analysis of 357 cases.
Righi A; Gambarotti M; Sbaraglia M; Sisto A; Ferrari S; Dei Tos AP; Picci P
Hum Pathol; 2016 Dec; 58():15-23. PubMed ID: 27544803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
